Evidence. Care. Accountability.Contact the desk
Our standards

Research explained

BPC-157 and sphincter pressure after NSAID challenges

Pressure recovery in rats does not establish reflux relief or protection from NSAID injury in people.

On this page

Evidence dossier

The report behind the claim

The investigators reported attenuation of drug-associated pressure reductions. Pressure recovery in rats does not establish reflux relief or protection from NSAID injury in people.

Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gatric pentadecapeptide BPC 157 in rats.

Design
Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
Participants or model
Rats exposed to several gastrointestinal drug-injury regimens
Endpoint
Lower-esophageal and pyloric sphincter pressure
Finding on record
The investigators reported attenuation of drug-associated pressure reductions.
Limits of inference
Pressure recovery in rats does not establish reflux relief or protection from NSAID injury in people.
Read the publication

The experiment in view

The study used rats exposed to several gastrointestinal drug-injury regimens. Its principal measures were lower-esophageal and pyloric sphincter pressure. The investigators reported attenuation of drug-associated pressure reductions.

Reading the result closely

A manometry result is narrower than a patient's symptom, endoscopy result or bleeding outcome. The paper's focus on pressure should be preserved even though other injuries are discussed. Different causative drugs do not create identical clinical questions simply because the same pressure measurement changes.

The boundary of the finding

Pressure recovery in rats does not establish reflux relief or protection from NSAID injury in people.

Related evidence, kept separate

BPC-157 in a high-dose celecoxib rat model examines gastric, liver and brain lesions and liver enzymes. Here, the measured endpoint was lower-esophageal and pyloric sphincter pressure. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the BPC-157 and nitric oxide: a blood-pressure effect is not automatically desirable appraisal.

On the record

The documents supporting this report.

  1. BPC-157 and sphincter pressure after NSAID challenges — original indexed research

The continuing record

More from the report

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review